Oct 10 (Reuters) – Johnson & Johnson is in discussions to buy Protagonist Therapeutics, the Wall Street Journal reported on Friday, citing people familiar with the matter. Shares of Protagonist were up 9.4% in morning trade. (Reporting by Kamal Choudhury in Bengaluru; Editing by Anil D'Silva)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Maria Tsvetkova and Nathan Layne NEW YORK, July 3 (Reuters) - Pop music megastar…
By Lisa Richwine July 3 (Reuters) - Adam Sandler, the comic actor known for goofball…
By Maria Tsvetkova and Nathan Layne NEW YORK, July 3 (Reuters) - Pop music megastar…
July 3 (Reuters) - American popstar Taylor Swift and NFL tight end Travis Kelce have…
By Maria Tsvetkova and Nathan Layne NEW YORK, July 3 (Reuters) - Pop music megastar…
July 3 (Reuters) - American popstar Taylor Swift and NFL tight end Travis Kelce have…